v_content=[['','

ImQuest scientist Dr. Bob Buckheit was invited to present a plenary lecture at Microbicides 2008 in Delhi India, introducing the pyrimidinediones during the session "New Approaches to Microbicide Candidates". Karen Watson presented three papers on the microbicide work being performed at ImQuest on IQP-0528, IQP-0831, and novel assay development. more »',''],['','',''],['','ImQuest scientists have published the results of an important structure activity relationship study with the dual acting pyrimidinediones in Antiviral Chemistry and Chemotherapy. more »',''],['','',''],['','Dr. Robert Buckheit has been named to head the Program Committee for the 2008 International Conference on Antiviral Research to be held in Montreal, Canada. Dr. Buckheit will be responsible for the organization of the 2008 meeting and is currently hard at work on the selection of plenary speakers and symposium sessions. This years meetng will feature a session on the development of inhibitors to novel HIV targets. more »',''],['','',''],['','Dr. Robert Buckheit (PI) and ImQuest have received a Phase 2 SBIR from the NIH to continue the development of the pyrimidinedione anti-HIV compounds as topical microbicides. The Phase 2 award will be performed in collaboration with Patrick Kiser at The University of Utah who will be working on the development of a formulated topical microbicide product. more »',''],['','',''],['','A manuscript authored by Robert Buckheit, Tracy Hartman and Karen Watson has been accepted for publication in Antiviral Chemistry and Chemotherapy.This work details the structure activity relationships among the pyrimidinedione HIV inhibitors. more »',''],['','',''],['','ImQuest announces the successful completion of the first development milestone in their work with International Partnership for Microbicides and progression to advanced toxicology and formulation studies for development of the pyrimidinedione topical microbicides. more »',''],['','',''],['','ImQuest announces the initiation of studies supported by The International partnership for Microbicides to develop the viral inactivating NCp7 inhibitors as potential topical microbicides. more »',''],['','',''],['','

','']];